Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
RFL

RFL - Rafael Holdings Inc Stock Price, Fair Value and News

$1.21+0.01 (+0.83%)
Market Closed

45/100

RFL

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

45/100

RFL

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$1.17

Target 3M

$1.2

Target 6M

$1.19

RFL Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RFL Price Action

Last 7 days

0.8%

Last 30 days

1.7%

Last 90 days

-10.4%

Trailing 12 Months

-41.0%

RFL RSI Chart

RFL Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

RFL Valuation

Market Cap

61.9M

Price/Earnings (Trailing)

-3.17

Price/Sales (Trailing)

32.49

EV/EBITDA

-0.5

Price/Free Cashflow

-2.73

RFL Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$1.17

Target 3M

$1.2

Target 6M

$1.19

RFL Fundamentals

RFL Revenue

Revenue (TTM)

1.9M

Rev. Growth (Yr)

-29.75%

Rev. Growth (Qtr)

-14.56%

RFL Earnings

Earnings (TTM)

-19.5M

Earnings Growth (Yr)

-8.99%

Earnings Growth (Qtr)

-3.3K%

RFL Profitability

Operating Margin

91.18%

EBT Margin

-1772.67%

Return on Equity

-22.92%

Return on Assets

-18.53%

Free Cashflow Yield

-36.63%

RFL Investor Care

Shares Dilution (1Y)

112.71%

Diluted EPS (TTM)

-0.87

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202502.1M2.1M1.9M
20249.1M8.0M7.7M7.7M
202303.2M4.2M4.7M
2022682.0K562.0K201.0K1.7M
20219.1M8.0M1.7M802.0K
20205.2M5.1M10.4M10.3M
20194.4M4.7M4.9M5.0M
20185.2M5.0M4.7M4.4M
20175.6M5.6M5.6M5.6M
2016005.6M0
Get all data in R, Python etc through our Historical Stock Data APIs

About Rafael Holdings Inc

RFL
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), that is in Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.
 WEBSITErafaelholdings.com
 SECTORReal Estate
 INDUSTRYReal Estate Services
 EMPLOYEES22

Rafael Holdings Inc Frequently Asked Questions

RFL is the stock ticker symbol of Rafael Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Rafael Holdings Inc is 61.93 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check RFL's fair value in chart for subscribers.

The fair value guage provides a quick view whether RFL is over valued or under valued. Whether Rafael Holdings Inc is cheap or expensive depends on the assumptions which impact Rafael Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for RFL.

As of Wed Jan 28 2026, RFL's PE ratio (Price to Earnings) is -3.17 and Price to Sales (PS) ratio is 32.49. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. RFL PE ratio will change depending on the future growth rate expectations of investors.